These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1903196)

  • 1. Transfected mouse c-jun can inhibit transformation of primary rat embryo fibroblasts.
    Ginsberg D; Hirai SI; Pinhasi-Kimhi O; Yaniv M; Oren M
    Oncogene; 1991 Apr; 6(4):669-72. PubMed ID: 1903196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of oncogene-induced transformation by a deletion mutant of c-jun.
    Brown PH; Alani R; Preis LH; Szabo E; Birrer MJ
    Oncogene; 1993 Apr; 8(4):877-86. PubMed ID: 8455942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions.
    Koskinen PJ; Ayer DE; Eisenman RN
    Cell Growth Differ; 1995 Jun; 6(6):623-9. PubMed ID: 7669717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of avian or mouse c-jun in primary chick embryo fibroblasts confers a partially transformed phenotype.
    Castellazzi M; Dangy JP; Mechta F; Hirai S; Yaniv M; Samarut J; Lassailly A; Brun G
    Oncogene; 1990 Oct; 5(10):1541-7. PubMed ID: 2123532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation.
    Su ZZ; Yemul S; Stein CA; Fisher PB
    Oncogene; 1995 May; 10(10):2037-49. PubMed ID: 7761104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The defective transforming phenotype of c-Jun Ala(63/73) is rescued by mutation of the C-terminal phosphorylation site.
    Bost F; Caron L; Vial E; Montreau N; Marchetti I; Dejong V; Defize L; Castellazzi M; Binétruy B
    Oncogene; 2001 Nov; 20(50):7425-9. PubMed ID: 11704873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects by Mad and Max on transformation by cellular and viral oncoproteins.
    Cerni C; Bousset K; Seelos C; Burkhardt H; Henriksson M; Lüscher B
    Oncogene; 1995 Aug; 11(3):587-96. PubMed ID: 7630643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transformation suppressor activity of a Jun transcription factor lacking its activation domain.
    Lloyd A; Yancheva N; Wasylyk B
    Nature; 1991 Aug; 352(6336):635-8. PubMed ID: 1907719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation.
    Vaqué JP; Fernández-García B; García-Sanz P; Ferrandiz N; Bretones G; Calvo F; Crespo P; Marín MC; León J
    Mol Cancer Res; 2008 Feb; 6(2):325-39. PubMed ID: 18314492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
    Choe C; Chen N; Sawadogo M
    Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
    Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
    Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
    Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
    Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
    Morello D; Lavenu A; Babinet C
    Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation.
    Hartl M; Bister K
    Oncogene; 1998 Dec; 17(22):2901-13. PubMed ID: 9879996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of PC-12 cell differentiation by the immediate early gene fra-1.
    Ito E; Sweterlitsch LA; Tran PB; Rauscher FJ; Narayanan R
    Oncogene; 1990 Dec; 5(12):1755-60. PubMed ID: 2178237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription factor ATF3 partially transforms chick embryo fibroblasts by promoting growth factor-independent proliferation.
    Perez S; Vial E; van Dam H; Castellazzi M
    Oncogene; 2001 Mar; 20(9):1135-41. PubMed ID: 11314051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
    Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
    Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditional cell transformation by doxycycline-controlled expression of the ASV17 v-jun allele.
    Bader AG; Hartl M; Bister K
    Virology; 2000 Apr; 270(1):98-110. PubMed ID: 10772983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro transforming capacities of mouse c-jun:junD chimeric genes.
    Métivier C; Piu F; Pfarr CM; Yaniv M; Loiseau L; Castellazzi M
    Oncogene; 1993 Aug; 8(8):2311-5. PubMed ID: 8336952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of c-jun expression in a transformed cell line isolated by glucocorticoid promotion of ras-transfected rat embryo fibroblasts.
    Marshall H; Popowicz P; Engel G; Martens I; Linder S
    Oncogene; 1993 May; 8(5):1303-9. PubMed ID: 8479751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.